Resolve Therapeutics logo

Resolve Therapeutics

A biopharmaceutical company that develops biologic products to treat lupus and other autoimmune diseases

2

Funding Rounds

$7.8m

Money raised

Overview

A biopharmaceutical company that develops biologic products to treat lupus and other autoimmune diseases

Funding

Funding series

Funding Series Analysis

The company Resolve Therapeutics has raised a total of $7.8m in funding over 2 rounds.

Key Insights:

  • Resolve Therapeutics Series B round: $5.8m
  • Resolve Therapeutics Series A round: $2m
Resolve Therapeutics logo
Resolve Therapeutics Series B round $5.8m
Resolve Therapeutics logo
Resolve Therapeutics Series A round $2m

Industries

Resolve Therapeutics is active in the following industries: